PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,350 Cr | ₹2,134 Cr | ₹1,799 Cr | ₹1,785 Cr | ₹1,575 Cr |
What is the latest Sundry Debtors ratio of PIRAMAL PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹2,350 Cr |
| Mar2024 | ₹2,134 Cr |
| Mar2023 | ₹1,799 Cr |
| Mar2022 | ₹1,785 Cr |
| Mar2021 | ₹1,575 Cr |
How is Sundry Debtors of PIRAMAL PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,350 Cr | 10.08 | |
| Mar2024 | ₹2,134 Cr | 18.62 | |
| Mar2023 | ₹1,799 Cr | 0.79 | |
| Mar2022 | ₹1,785 Cr | 13.36 | |
| Mar2021 | ₹1,575 Cr | - | |
Compare Sundry Debtors of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹23,626.5 Cr | 5.4% | -5.6% | -35.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,982.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,878.0 Cr | 2.8% | 2.2% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,095.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹122,175.0 Cr | 0.8% | 0.1% | 3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,154.0 Cr | 0.4% | 3.2% | 0.3% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 5.4% |
-5.6% |
-35.4% |
| SENSEX | 0.4% |
-0.1% |
6.1% |
You may also like the below Video Courses